Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 01 NOVEMBER 2018

Digital Transformation In Biopharma: Time For A Sea Change In Strategy

Deloitte
Explore more from Deloitte

Deloitte recently conducted a survey with the MIT Sloan Management Review to assess the digital maturity of companies across a wide variety of industries.

United KingdomStrategy
Mark Steedman
Mark Steedman
Author LinkedIn connections

Deloitte recently conducted a survey with the MIT Sloan Management Review to assess the digital maturity of companies across a wide variety of industries.1 Our colleagues in the US Center for Health Solutions analysed the responses from biopharma companies and published them in a separate report - Survey finds biopharma companies lag in digital transformation: It is time for a sea change in strategy.2 Headlining the report is the finding that only 20 per cent of biopharma respondents think their companies are digitally mature, compared to 30 per cent across all industries.3 

This report and its findings caused me to reflect on our own work in this area. Each December we publish the latest report in our series Measuring the return from pharmaceutical innovation. Our 2017 report A new future for R&D? found the pharmaceutical industry continues to face an extremely challenging R&D environment; the cost to bring a drug to market has nearly doubled, while the projected

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

Preparing For The EU Cyber Resilience Act: Key Reporting Obligations From 11 September 2026

The EU's Cyber Resilience Act introduces mandatory cybersecurity reporting obligations for manufacturers of digital products starting September 2026, requiring notification of actively exploited vulnerabilities and severe incidents within strict timeframes. Companies must establish procedures to identify and report security events to national Computer Security Incident Response Teams, with potential fines reaching €15 million or 2.5% of global turnover for non-compliance.
United KingdomStrategy
Goodwin Procter LLP
Goodwin Procter LLP
Article

European Commission Proposes European Innovation Act

The European Commission has unveiled a European Innovation Act designed to strengthen the EU's innovation ecosystem by addressing two critical challenges: limited access to finance for IP-rich businesses and fragmented regulatory frameworks across Member States. The proposal introduces measures including a common IP valuation framework, streamlined R&D procurement procedures, and harmonized regulatory sandboxes to help startups and scaleups commercialize their innovations more effectively.
European UnionStrategy
Lewis Silkin
Lewis Silkin
Article

The SRA’s AI Warning Notice: A Regulatory Wake-up Call, Not A Reason To Step Back

The Solicitors Regulation Authority has issued a warning notice on AI misuse in legal practice, clarifying what responsible adoption looks like. While recognizing AI's benefits for document review, drafting, and research, the regulator emphasizes that solicitors remain accountable for their work regardless of the tools used, requiring proper governance, human oversight, and professional judgment to manage risks like hallucinated citations and confidentiality breaches.
United KingdomStrategy
Gateley Legal
Gateley Legal